🧬 African Antimicrobial Research & Innovation Program (AARIP)

Leading Africa's response to antimicrobial resistance through research, innovation, and advocacy.

About AARIP

AARIP is AMRIF's flagship program dedicated to addressing the growing threat of antimicrobial resistance (AMR) across Africa. Through cutting-edge research, innovation, and strategic partnerships, we're working to develop African-led solutions to one of the most pressing global health challenges.

Antimicrobial resistance threatens to reverse decades of medical progress, making infections harder to treat and increasing mortality rates. AARIP tackles this challenge head-on through research, capacity building, and policy advocacy.

AARIP Research

What AARIP Does

AMR Research

Conduct and support research on antimicrobial resistance patterns, mechanisms, and novel therapeutic approaches.

Surveillance & Monitoring

Support AMR surveillance systems to track resistance patterns and inform public health responses.

Drug Discovery

Explore African biodiversity for novel antimicrobial compounds and support drug development pipelines.

Capacity Building

Train researchers, healthcare workers, and laboratory personnel in AMR diagnostics and stewardship.

Policy Advocacy

Advocate for evidence-based AMR policies and support National Action Plans across African countries.

Global Partnerships

Collaborate with international organizations and research institutions to address AMR globally.

Why AMR Matters

Antimicrobial resistance is projected to cause 10 million deaths annually by 2050 if left unchecked. Africa, with its high infectious disease burden and limited healthcare infrastructure, is particularly vulnerable.

700K+

Deaths annually from drug-resistant infections

$100T

Projected economic impact by 2050

4.95M

Deaths associated with AMR in 2019

Join the Fight Against AMR

Partner with AARIP to combat antimicrobial resistance in Africa.

Partner with Us Back to Programs